STAT6h
Trump’s FDA transition team takes shape with former Hahn adviser, courts top Capitol Hill aide
Trump's staff is laying the groundwork to prepare for a new FDA commissioner and make their mark at the agency.
Cucumber Recall Update As FDA Awards Highest Risk Level
The impacted products have now been given a Class I risk classification by the U.S. Food and Drug Administration.
FDA issues recall warning for some batches of broccoli, oysters, sold in Oregon
The Food and Drug Administration said that consumers should avoid eating the possibly norovirus-contaminated oysters and a ...
Eli Lilly asks to join FDA in opposing lawsuit from pharmacies
CNBC's Becky Quick reports on news from Eli Lilly. US surgeon general urges cancer warnings for alcoholic drinks 14 Trader ...
Convenience Store News3h
FDA Clarifies Import Alerts on Detention of Unauthorized E-Cigarettes, Smokeless Tobacco and Nicotine Pouches
In October, the FDA in collaboration with the U.S. Customs and Border Protection (CBP), seized about three million units of ...
medtechdive8h
FDA closes 2024 with string of early alerts on device safety risks
Olympus advised providers to stop using an endoscope accessory due to an infection risk linked to 120 injuries and one death.
Monthly Prescribing Reference4h
FDA Drug Approval Decisions Expected in February 2025
The FDA is expected to decide on treatments for Parkinson disease, PTSD and NF1-associated plexiform neurofibromas, in addition to 2 new vaccines.
The FDA’s Evolving Role in Public Health
A discussion of the development of consumer protection law in the US through the enactment of key legislation and formation ...
Pharma giant seeks to join lawsuit against FDA over weight loss drugs
Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by ...
STAT3d
3 key issues to watch at the FDA as Trump takes office
With Donald Trump taking office and Robert F. Kennedy Jr. poised to assume the nation’s top health role, it seems the agency ...
FiercePharma1d
Lilly looks to 'protect its interests' by moving to join FDA lawsuit over compounded tirzepatide
After plugging billions into its manufacturing network to meet rampant demand for Mounjaro and Zepbound, Eli Lilly is looking ...
Targeted Oncology9h
FDA’s December 2024 Oncology Approvals and Designations
On December 20, 2024, the FDA granted accelerated approval to the combination of encorafenib (Braftovi), cetuximab (Erbitux), and mFOLFOX6 (fluorouracil, leucovorin, and oxaliplatin) in metastatic ...